These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12023034

  • 1. Endostatin binds to the catalytic domain of matrix metalloproteinase-2.
    Lee SJ, Jang JW, Kim YM, Lee HI, Jeon JY, Kwon YG, Lee ST.
    FEBS Lett; 2002 May 22; 519(1-3):147-52. PubMed ID: 12023034
    [Abstract] [Full Text] [Related]

  • 2. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
    Kim YM, Jang JW, Lee OH, Yeon J, Choi EY, Kim KW, Lee ST, Kwon YG.
    Cancer Res; 2000 Oct 01; 60(19):5410-3. PubMed ID: 11034081
    [Abstract] [Full Text] [Related]

  • 3. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 4. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
    Xu X, Mikhailova M, Chen Z, Pal S, Robichaud TK, Lafer EM, Baber S, Steffensen B.
    Matrix Biol; 2011 Sep 15; 30(7-8):404-12. PubMed ID: 21839835
    [Abstract] [Full Text] [Related]

  • 5. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE.
    Atherosclerosis; 2008 Jun 15; 198(2):320-31. PubMed ID: 18054360
    [Abstract] [Full Text] [Related]

  • 6. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M.
    EMBO J; 2001 Sep 03; 20(17):4782-93. PubMed ID: 11532942
    [Abstract] [Full Text] [Related]

  • 7. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 8. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
    Lafleur MA, Tester AM, Thompson EW.
    FEBS Lett; 2003 Oct 23; 553(3):457-63. PubMed ID: 14572669
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
    Shimada T, Nakamura H, Ohuchi E, Fujii Y, Murakami Y, Sato H, Seiki M, Okada Y.
    Eur J Biochem; 1999 Jun 23; 262(3):907-14. PubMed ID: 10411655
    [Abstract] [Full Text] [Related]

  • 10. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M, Tordai H, Trexler M, Bányai L, Patthy L.
    Biochimie; 2005 Jun 23; 87(3-4):385-92. PubMed ID: 15781326
    [Abstract] [Full Text] [Related]

  • 11. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J, Pei D.
    Cancer Res; 2003 Oct 15; 63(20):6758-62. PubMed ID: 14583471
    [Abstract] [Full Text] [Related]

  • 12. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
    Knäuper V, Bailey L, Worley JR, Soloway P, Patterson ML, Murphy G.
    FEBS Lett; 2002 Dec 04; 532(1-2):127-30. PubMed ID: 12459476
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
    Kido A, Tsutsumi M, Iki K, Motoyama M, Takahama M, Tsujiuchi T, Morishita T, Tatsumi K, Tamai S, Konishi Y.
    Jpn J Cancer Res; 1999 Mar 04; 90(3):333-41. PubMed ID: 10359049
    [Abstract] [Full Text] [Related]

  • 14. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
    Matsumoto S, Katoh M, Saito S, Watanabe T, Masuho Y.
    Biochim Biophys Acta; 1997 Nov 01; 1354(2):159-70. PubMed ID: 9396633
    [Abstract] [Full Text] [Related]

  • 15. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity.
    Freise C, Erben U, Muche M, Farndale R, Zeitz M, Somasundaram R, Ruehl M.
    Matrix Biol; 2009 Oct 01; 28(8):480-9. PubMed ID: 19698785
    [Abstract] [Full Text] [Related]

  • 16. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 01; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 17. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y.
    Eur J Biochem; 1998 Apr 01; 253(1):67-75. PubMed ID: 9578462
    [Abstract] [Full Text] [Related]

  • 18. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y, Binner S, Nagase H.
    Biochem J; 1995 Jun 01; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [Abstract] [Full Text] [Related]

  • 19. In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.
    Rigot V, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y.
    Biochem J; 2001 Aug 15; 358(Pt 1):275-80. PubMed ID: 11485578
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T, Konishi Y.
    Carcinogenesis; 1999 Jul 15; 20(7):1323-9. PubMed ID: 10383907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.